カテゴリー： 世界, 医療/バイオ, MarketsandMarkets

世界の医療シミュレーション市場（～2028年）：提供別（シミュレーション（患者-忠実度、外科-腹腔鏡、CVD、整形、脊椎、婦人科、超音波）、トレーニングサービス）、技術別（3Dプリント、バーチャル患者、手術リハーサル）、エンドユーザー別、地域別

【英語タイトル】Healthcare Simulation Market by Offering (Simulation (Patient -Fidelity, Surgical - Laparoscopic, CVD, Ortho, Spine, Gynae, Ultrasound), Training Services), Technology (3D printing, virtual patient, procedural rehearsal), End User & Region - Global Forecast to 2028

MarketsandMarketsが出版した調査資料（HIT2828-24）・商品コード：HIT2828-24
・発行会社（調査会社）：MarketsandMarkets
・発行日：2024年1月18日
・ページ数：359
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

“世界の医療シミュレーション市場は、2023年の23億米ドルから2028年には52億米ドルに達すると予測され、予測期間中の年平均成長率は16.7％と高い”市場拡大の原動力は、患者の安全性の重視の高まりと、バーチャルな相互作用への嗜好の高まりです。とはいえ、熟練した医療従事者の不足やシミュレータの高コストといった課題は、市場の成長をやや妨げるものと予想されます。

“製品・サービス別では、ウェブベースのシミュレーション分野が医療シミュレーション市場で最も大きな伸びを示す”
製品・サービス別では、ウェブベースのシミュレーション分野が予測期間を通じて医療シミュレーション市場で最も大きな成長を遂げました。同分野の拡大は、インターネットサービスの普及や、医療情報技術（HCIT）ソリューションの導入に向けた政府の取り組みが活発化していることに起因しています。

“2022年の医療シミュレーション市場におけるエンドユーザー別最大セグメントは学術機関”
2022年の医療シミュレーション市場では、学術機関分野が最も高い成長率を示すと予測されています。医療手術におけるシミュレーションモデルの使用の増加、エラー削減の重視の高まり、医療従事者向け手技トレーニングの費用対効果などが、今後数年間における医療シミュレーションサービスの需要を促進すると予測されます。

“アジア太平洋は予測期間を通じて最も大幅な成長率を経験する見込み”
アジア太平洋が医療シミュレーション市場において最も高い成長率を示しているのは、同地域全体で医療における高度な医療トレーニングと患者の安全性の重要性に対する認識が高まっていること、医療インフラと教育への投資の増加がシミュレーション技術の導入に寄与していること、技術の進歩と相まって熟練した医療従事者に対する需要の高まりが革新的なトレーニング方法の必要性を煽っていること、といったいくつかの要因によるものです。これらの要因が組み合わさることで、同地域は医療シミュレーションソリューションの市場としてダイナミックに急拡大しています。

主な参入企業の内訳は以下の通りです：

- 企業タイプ別 - ティア1：45％、ティア2：30％、ティア3：25％
- 役職別 - Cレベル：42％、ディレクターレベル：31％、その他：27％
- 地域別 - 北米：32％、ヨーロッパ：32％、アジア太平洋：26％、中東・アフリカ：5％、中南米：5％

医療シミュレーション市場の主要プレーヤー

医療シミュレーション市場で機能する主要企業には、CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK), Kyoto Kagaku (Japan), Mentice AB (Sweden), Gaumard Scientific Co. (US), Operative Experience Inc. (US), Cardionics Inc. (US) (a subsidiary of 3B Scientific), VirtaMed AG (Switzerland), SYNBONE AG (Switzerland), IngMar Medical (US), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Altay Scientific (Italy), Simendo B.V. (Netherlands) VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), Inovus Medical (UK), TruCorp Ltd. (Ireland), Surgical Science Sweden AG (Sweden)などが含まれます。

調査範囲

この調査レポートは医療シミュレーション市場を分析しています。製品・サービス、エンドユーザー、地域に基づく様々な市場セグメントの市場規模と今後の成長可能性を推定することを目的としています。また、同市場における主要企業の競争分析も行い、企業プロフィール、製品提供、最近の動向、主要市場戦略などを掲載しています。

レポート購入の理由

本レポートは、既存企業や新規参入企業/小規模企業が市場の動向を把握するのに役立ち、ひいては市場シェアを拡大するのに役立ちます。本レポートを購入された企業は、以下の戦略の1つまたは組み合わせを使用して、市場での地位を強化することができます。

本レポートは以下の洞察を提供します：

- 医療シミュレーション市場の成長に影響を与える主な促進要因（医療トレーニング中の患者へのアクセス制限、医療教育における技術進歩の高まり）、阻害要因（患者の安全性への注目の高まり、バーチャルインタラクションへの嗜好の高まり）、機会（新興国におけるシミュレーショントレーニングに対する意識の高まり）、課題（シミュレータの高コスト、運用上の課題）に関する分析しました。
- 製品開発/イノベーション： 医療シミュレーション市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な洞察を提供します。
- 市場開発： 有利な新興市場、製品・サービス、エンドユーザー、地域に関する包括的情報を記載しています。
- 市場の多様化： 医療シミュレーション市場における製品ポートフォリオ、成長地域、最新動向、投資に関する詳細情報を記載しています。
- 競合他社の評価：CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK)など、医療シミュレーション市場の主要企業の市場シェア、成長戦略、製品提供、能力を詳細に評価しています。

1.　序論
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の医療シミュレーション市場規模：製品・サービス別
7.　世界の医療シミュレーション市場規模：技術別
8.　世界の医療シミュレーション市場規模：エンドユーザー別
9.　世界の医療シミュレーション市場規模：地域別
10.　競争状況
11.　企業情報
12.　付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION AND SCOPE 40
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.2.2 MARKET SCOPE 41
FIGURE 1 HEALTHCARE SIMULATION MARKET SEGMENTATION 41
1.2.3 REGIONAL SCOPE 42
1.2.4 YEARS CONSIDERED 42
1.3 CURRENCY CONSIDERED 43
1.4 UNITS CONSIDERED 43
TABLE 1 EXCHANGE RATES CONSIDERED FOR CONVERSION TO USD 43
1.5 STAKEHOLDERS 43
1.6 SUMMARY OF CHANGES 44
1.7 RECESSION IMPACT 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH APPROACH 45
2.2 HEALTHCARE SIMULATION MARKET: RESEARCH DESIGN 45
2.2.1 SECONDARY RESEARCH 46
2.2.1.1 Key data from secondary sources 47
2.2.2 PRIMARY DATA 47
FIGURE 2 PRIMARY SOURCES 47
2.2.2.1 Key data from primary sources 48
2.2.2.2 Insights from primary experts 49
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION 49
2.3 MARKET SIZE ESTIMATION: HEALTHCARE SIMULATION MARKET 50
FIGURE 4 ESTIMATION OF MARKET SIZE FOR HEALTHCARE SIMULATION ACADEMIC INSTITUTES AND HOSPITALS THROUGH DEMAND-SIDE APPROACH 50
FIGURE 5 ESTIMATION OF GLOBAL HEALTHCARE SIMULATION MARKET SIZE THROUGH DEMAND-SIDE APPROACH 51
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 51
FIGURE 7 BOTTOM-UP APPROACH: SEGMENTAL EXTRAPOLATION 52
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 10 DATA TRIANGULATION 55
2.5 MARKET SHARE ESTIMATION 56
2.6 RESEARCH ASSUMPTIONS 56
2.7 RESEARCH LIMITATIONS 57
2.7.1 METHODOLOGY-RELATED LIMITATIONS 57
2.7.2 SCOPE-RELATED LIMITATIONS 57
2.8 RISK ASSESSMENT 57
TABLE 2 RISK ASSESSMENT: HEALTHCARE SIMULATION MARKET 57
2.9 RECESSION IMPACT ANALYSIS 57
3 EXECUTIVE SUMMARY 58
FIGURE 11 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 12 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 59
FIGURE 13 HEALTHCARE SIMULATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 HEALTHCARE SIMULATION MARKET: REGIONAL SNAPSHOT 61
4 PREMIUM INSIGHTS 62
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE SIMULATION MARKET 62
FIGURE 15 ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO DRIVE NORTH AMERICAN MARKET GROWTH 62
4.2 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE AND COUNTRY 63
FIGURE 16 HEALTHCARE SIMULATION ANATOMICAL MODELS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC 63
4.3 HEALTHCARE SIMULATION MARKET: REGIONAL GROWTH OPPORTUNITIES 64
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 64
4.4 REGIONAL MIX: HEALTHCARE SIMULATION MARKET 65
FIGURE 18 NORTH AMERICA TO LEAD HEALTHCARE SIMULATION MARKET DURING FORECAST PERIOD 65
4.5 HEALTHCARE SIMULATION MARKET: EMERGING VS. DEVELOPED ECONOMIES 66
FIGURE 19 EMERGING COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 20 HEALTHCARE SIMULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
5.3 MARKET DYNAMICS: IMPACT ANALYSIS 68
5.3.1 DRIVERS 68
5.3.1.1 Limited access to patients during medical training 68
5.3.1.2 Rising technological advancements in medical education 69
5.3.1.3 Growing demand for minimally invasive treatments 69
FIGURE 21 TOP MINIMALLY INVASIVE COSMETIC PROCEDURES PERFORMED IN 2022 70
5.3.1.4 Increasing focus on patient safety 70
5.3.1.5 Growing preference for virtual interaction 71
5.3.2 RESTRAINTS 71
5.3.2.1 Limited availability of funds 71
5.3.2.2 Poorly designed medical simulators 71
5.3.3 OPPORTUNITIES 72
5.3.3.1 Shortage of healthcare personnel 72
5.3.3.2 Growing awareness about simulation training in emerging economies 72
5.3.4 CHALLENGES 73
5.3.4.1 High cost of simulators 73
5.3.4.2 Operational challenges 73
5.4 INDUSTRY TRENDS 74
5.4.1 USE OF VIRTUAL REALITY AND AUGMENTED REALITY IN HEALTHCARE SIMULATION 74
5.4.2 HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS 74
5.4.3 MULTIMODAL APPROACH IN DEVELOPMENT OF SIMULATORS 75
5.4.4 UTILIZATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE IN SURGICAL PROCEDURES 75
5.4.5 GROWING USE OF HCIT/EMR 76
5.5 TECHNOLOGY ANALYSIS 76
5.5.1 INTEGRATION OF ARTIFICIAL INTELLIGENCE AND VIRTUAL REALITY 77
5.6 ECOSYSTEM ANALYSIS 77
FIGURE 22 HEALTHCARE SIMULATION MARKET: ECOSYSTEM 77
5.7 VALUE CHAIN ANALYSIS 78
FIGURE 23 HEALTHCARE SIMULATION MARKET: VALUE CHAIN ANALYSIS 79
5.8 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 3 HEALTHCARE SIMULATION MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.8.1 THREAT OF NEW ENTRANTS 80
5.8.2 THREAT OF SUBSTITUTES 80
5.8.3 BARGAINING POWER OF SUPPLIERS 80
5.8.4 BARGAINING POWER OF BUYERS 80
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.9 PATENT ANALYSIS 81
5.9.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE SIMULATION MARKET 81
FIGURE 24 PATENT PUBLICATION TRENDS (2013–2023) 81
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 82
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) OF HEALTHCARE SIMULATION PATENTS (JANUARY 2013–DECEMBER 2023) 82
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE SIMULATION PATENTS (JANUARY 2013–DECEMBER 2023) 83
5.9.3 LIST OF MAJOR PATENTS 83
TABLE 4 KEY PATENTS IN HEALTHCARE SIMULATION MARKET 83
5.10 TARIFF AND REGULATORY LANDSCAPE 85
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 8 HEALTHCARE SIMULATION MARKET: REGULATORY STANDARDS 88
5.10.2 HEALTHCARE SIMULATION PRODUCTS 88
5.10.2.1 North America 88
5.10.2.1.1 US 88
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 89
5.10.2.1.2 Canada 89
5.10.2.2 Europe 89
5.10.2.3 Asia Pacific 89
5.10.2.3.1 Japan 89
TABLE 10 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 90
5.10.2.3.2 China 90
TABLE 11 NMPA MEDICAL DEVICE CLASSIFICATION 90
5.10.2.3.3 India 91
5.10.3 INTEROPERABILITY STANDARDS 91
TABLE 12 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM 91
TABLE 13 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM 94
5.11 PRICING ANALYSIS 94
5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 94
FIGURE 27 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 94
TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 95
5.11.2 REGIONAL PRICING ANALYSIS OF MEDICAL SIMULATORS 95
5.12 HEALTHCARE SIMULATION MARKET INVESTMENT LANDSCAPE 95
FIGURE 28 HEALTHCARE SIMULATION FUNDING IN 2022 95
FIGURE 29 MOST VALUED HEALTHCARE SIMULATION FIRMS IN 2022 (USD BILLION) 96
5.13 KEY CONFERENCES AND EVENTS (Q4 2023–Q3 2024) 96
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 97
FIGURE 30 REVENUE SHIFT IN HEALTHCARE SIMULATION MARKET 97
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 98
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 98
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 98
5.15.2 BUYING CRITERIA 99
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 99
TABLE 16 KEY BUYING CRITERIA FOR TOP THREE END USERS 99
5.16 CASE STUDY ANALYSIS 100
5.16.1 CASE STUDY 1 100
5.16.2 CASE STUDY 2 101
5.17 UNMET NEEDS 101
TABLE 17 UNMET NEEDS IN HEALTHCARE SIMULATION MARKET 101
5.17.1 END USER EXPECTATIONS 102
TABLE 18 END USER EXPECTATIONS IN HEALTHCARE SIMULATION MARKET 102
6 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE 104
6.1 INTRODUCTION 105
TABLE 19 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 105
6.2 HEALTHCARE SIMULATION ANATOMICAL MODELS 105
TABLE 20 HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 21 HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.2.1 PATIENT SIMULATORS 107
TABLE 22 KEY PLAYERS OFFERING PATIENT SIMULATORS 108
TABLE 23 PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 24 PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
TABLE 25 PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
6.2.1.1 By type 111
6.2.1.1.1 High-fidelity simulators 111
6.2.1.1.1.1 Growing adoption of high-fidelity simulators in educational training to drive growth 111
TABLE 26 KEY MARKET PLAYERS OFFERING HIGH-FIDELITY SIMULATORS 112
TABLE 27 HIGH-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.2.1.1.2 Medium-fidelity simulators 113
6.2.1.1.2.1 Cost benefits of medium-fidelity simulation to drive demand 113
TABLE 28 KEY MARKET PLAYERS OFFERING MEDIUM-FIDELITY SIMULATORS 113
TABLE 29 MEDIUM-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
6.2.1.1.3 Low-fidelity simulators 114
6.2.1.1.3.1 Budgetary constraints and ease of use to drive demand 114
TABLE 30 KEY MARKET PLAYERS OFFERING LOW-FIDELITY SIMULATORS 115
TABLE 31 LOW-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
6.2.1.2 By application 116
6.2.1.2.1 Laparoscopic surgical simulators 116
6.2.1.2.1.1 Increasing prevalence of minimally invasive surgeries to drive growth 116
TABLE 32 LAPAROSCOPIC SURGICAL PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
6.2.1.2.2 Gynecology simulators 117
6.2.1.2.2.1 Increasing incidence of fibroids and polyps in women to drive demand 117
TABLE 33 GYNECOLOGY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.2.1.2.3 Cardiovascular simulators 118
6.2.1.2.3.1 Increasing prevalence of diabetes to boost demand 118
TABLE 34 CARDIOVASCULAR PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.2.1.2.4 Orthopedic surgical simulators 119
6.2.1.2.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 119
TABLE 35 ORTHOPEDIC SURGICAL PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.2.1.2.5 Spine surgical simulators 120
6.2.1.2.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 120
TABLE 36 SPINE SURGICAL PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.2.1.2.6 Endovascular simulators 121
6.2.1.2.6.1 Reduced mortality rates associated with endovascular simulators to boost demand 121
TABLE 37 ENDOVASCULAR PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
6.2.1.2.7 Other applications in patient simulators 122
TABLE 38 PATIENT SIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.2.2 TASK TRAINERS 123
6.2.2.1 Inability to imitate emotional attributes of patients to restrain growth 123
TABLE 39 KEY MARKET PLAYERS OFFERING TASK TRAINERS 124
TABLE 40 TASK TRAINERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.2.3 INTERVENTIONAL/SURGICAL SIMULATORS 125
TABLE 41 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 42 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
6.2.3.1 Laparoscopic surgical simulators 127
6.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth 127
TABLE 43 KEY MARKET PLAYERS OFFERING LAPAROSCOPIC SURGICAL SIMULATORS 128
TABLE 44 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.2.3.2 Gynecology simulators 129
6.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators 129
TABLE 45 KEY MARKET PLAYERS OFFERING GYNECOLOGY SIMULATORS 129
TABLE 46 GYNECOLOGY SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.2.3.3 Cardiovascular simulators 130
6.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand 130
TABLE 47 KEY MARKET PLAYERS OFFERING CARDIOVASCULAR SIMULATORS 131
TABLE 48 CARDIOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
6.2.3.4 Orthopedic surgical simulators 132
6.2.3.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 132
TABLE 49 KEY MARKET PLAYERS OFFERING ORTHOPEDIC SIMULATORS 132
TABLE 50 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
6.2.3.5 Spine surgical simulators 133
6.2.3.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 133
TABLE 51 KEY MARKET PLAYERS OFFERING SPINE SURGICAL SIMULATORS 134
TABLE 52 SPINE SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
6.2.3.6 Endovascular simulators 135
6.2.3.6.1 Ability to reduce mortality rates to drive demand for endovascular simulators 135
TABLE 53 KEY MARKET PLAYERS OFFERING ENDOVASCULAR SIMULATORS 135
TABLE 54 ENDOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
6.2.3.7 Other surgical simulators 136
TABLE 55 KEY MARKET PLAYERS OFFERING OTHER SURGICAL SIMULATORS 137
TABLE 56 OTHER SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
6.2.4 ULTRASOUND SIMULATORS 138
6.2.4.1 Inferior quality images due to low dynamics and spatial resolution to restrain growth 138
TABLE 57 KEY MARKET PLAYERS OFFERING ULTRASOUND SIMULATORS 138
TABLE 58 ULTRASOUND SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
6.2.5 DENTAL SIMULATORS 140
6.2.5.1 Expanding dental tourism industry to drive growth 140
TABLE 59 KEY PLAYERS OFFERING DENTAL SIMULATORS 140
TABLE 60 DENTAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
6.2.6 EYE SIMULATORS 141
6.2.6.1 Increasing incidence of eye disorders to drive growth 141
TABLE 61 KEY PLAYERS OFFERING EYE SIMULATORS 142
TABLE 62 EYE SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
6.3 WEB-BASED SIMULATION 143
6.3.1 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF WEB-BASED SIMULATION 143
TABLE 63 KEY PLAYERS OFFERING WEB-BASED SIMULATORS 143
TABLE 64 WEB-BASED SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
6.4 HEALTHCARE SIMULATION SOFTWARE 144
6.4.1 KEY ADVANTAGES OFFERED BY HEALTHCARE SIMULATION SOFTWARE TO DRIVE ADOPTION 144
TABLE 65 KEY MARKET PLAYERS OFFERING HEALTHCARE SIMULATION SOFTWARE 145
TABLE 66 HEALTHCARE SIMULATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
6.5 HEALTHCARE SIMULATION TRAINING SERVICES 146
TABLE 67 HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 68 HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
6.5.1 VENDOR-BASED TRAINING 148
6.5.1.1 High focus on patient safety to drive demand 148
TABLE 69 KEY MARKET PLAYERS OFFERING VENDOR-BASED TRAINING SERVICES 148
TABLE 70 VENDOR-BASED TRAINING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
6.5.2 EDUCATIONAL SOCIETIES 149
6.5.2.1 Growing need for proper training and authenticity of knowledge to drive growth 149
TABLE 71 KEY PLAYERS OFFERING EDUCATIONAL SOCIETIES SIMULATORS 150
TABLE 72 EDUCATIONAL SOCIETIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
6.5.3 CUSTOM CONSULTING SERVICES 151
6.5.3.1 Growing need to limit errors associated with traditional medical training systems to drive growth 151
TABLE 73 KEY MARKET PLAYERS OFFERING CUSTOM CONSULTING SERVICES 151
TABLE 74 CUSTOM CONSULTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
7 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY 153
7.1 INTRODUCTION 154
TABLE 75 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
7.2 VIRTUAL PATIENT SIMULATION 154
7.2.1 INCREASING FOCUS ON AUGMENTED REALITY/VIRTUAL REALITY TO DRIVE MARKET 154
TABLE 76 VIRTUAL PATIENT SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
7.3 3D PRINTING 155
7.3.1 INCREASING ADOPTION IN MEDICAL TRAINING TO DRIVE MARKET 155
TABLE 77 3D PRINTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
7.4 PROCEDURAL REHEARSAL TECHNOLOGY 156
7.4.1 IMPROVING SURGICAL SKILLS WITH PROCEDURAL REHEARSAL TECHNOLOGY TO DRIVE MARKET 156
TABLE 78 PROCEDURAL REHEARSAL TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
8 HEALTHCARE SIMULATION MARKET, BY END USER 158
8.1 INTRODUCTION 159
TABLE 79 HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 159
8.2 ACADEMIC INSTITUTES 159
8.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND 159
TABLE 80 HEALTHCARE SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 160
8.3 HOSPITALS 160
8.3.1 RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND 160
TABLE 81 HEALTHCARE SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 161
8.4 MILITARY ORGANIZATIONS 162
8.4.1 EXPLORATION OF NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND 162
TABLE 82 HEALTHCARE SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 163
8.5 OTHER END USERS 163
TABLE 83 HEALTHCARE SIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
9 HEALTHCARE SIMULATION MARKET, BY REGION 165
9.1 INTRODUCTION 166
TABLE 84 HEALTHCARE SIMULATION MARKET, BY REGION, 2021–2028 (USD MILLION) 166
9.2 NORTH AMERICA 166
FIGURE 33 NORTH AMERICA: HEALTHCARE SIMULATION MARKET SNAPSHOT (2022) 167
TABLE 85 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 86 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 168
TABLE 87 NORTH AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 88 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 89 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 90 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 91 NORTH AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 92 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 93 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 171
9.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 171
9.2.2 US 172
9.2.2.1 Increasing demand for virtual tutors and high healthcare spending to boost growth 172
TABLE 94 US: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 95 US: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 96 US: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 97 US: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 98 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 99 US: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 100 US: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 175
TABLE 101 US: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 175
9.2.3 CANADA 175
9.2.3.1 Increasing funding and surgical capabilities to drive growth 175
TABLE 102 CANADA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 176
TABLE 103 CANADA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 104 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 105 CANADA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 106 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 107 CANADA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 108 CANADA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 109 CANADA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 179
9.3 EUROPE 179
TABLE 110 EUROPE: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 111 EUROPE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 112 EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 113 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 114 EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 115 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 116 EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 117 EUROPE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 183
TABLE 118 EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 183
9.3.1 EUROPE: RECESSION IMPACT ANALYSIS 184
9.3.2 UK 184
9.3.2.1 Rising number of healthcare simulation centers and hospitals to drive growth 184
TABLE 119 UK: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 185
TABLE 120 UK: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 121 UK: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 122 UK: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 186
TABLE 123 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 124 UK: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 125 UK: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 187
TABLE 126 UK: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 187
9.3.3 FRANCE 188
9.3.3.1 Growing focus on use of innovative methods in medical training to drive growth 188
TABLE 127 FRANCE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 188
TABLE 128 FRANCE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 129 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 130 FRANCE: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 190
TABLE 131 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 132 FRANCE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 133 FRANCE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 191
TABLE 134 FRANCE: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 191
9.3.4 GERMANY 192
9.3.4.1 High healthcare spending to drive growth 192
TABLE 135 GERMANY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 192
TABLE 136 GERMANY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 137 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 138 GERMANY: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194
TABLE 139 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 140 GERMANY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 141 GERMANY: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 195
TABLE 142 GERMANY: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 195
9.3.5 ITALY 196
9.3.5.1 Shortage of trained healthcare personnel to drive growth 196
TABLE 143 ITALY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 196
TABLE 144 ITALY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 145 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 146 ITALY: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 198
TABLE 147 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 148 ITALY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 149 ITALY: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 199
TABLE 150 ITALY: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 199
9.3.6 SPAIN 200
9.3.6.1 Increasing number of surgical procedures to boost growth 200
TABLE 151 SPAIN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 200
TABLE 152 SPAIN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 153 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 154 SPAIN: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 155 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 156 SPAIN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 157 SPAIN: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 203
TABLE 158 SPAIN: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 203
9.3.7 REST OF EUROPE 204
TABLE 159 REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 204
TABLE 160 REST OF EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 161 REST OF EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 162 REST OF EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 206
TABLE 163 REST OF EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 164 REST OF EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 165 REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 207
TABLE 166 REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 207
9.4 ASIA PACIFIC 208
FIGURE 34 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET SNAPSHOT (2022) 209
TABLE 167 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 210
TABLE 168 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 210
TABLE 169 ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 170 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 171 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 172 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 173 ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 174 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 213
TABLE 175 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 213
9.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 214
9.4.2 JAPAN 214
9.4.2.1 Increasing demand for virtual tutors and technologically advanced simulators to drive growth 214
TABLE 176 JAPAN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 215
TABLE 177 JAPAN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 178 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 179 JAPAN: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 216
TABLE 180 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 181 JAPAN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 182 JAPAN: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 217
TABLE 183 JAPAN: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 217
9.4.3 CHINA 218
9.4.3.1 Increasing demand for trained medical professionals to drive growth 218
TABLE 184 CHINA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 218
TABLE 185 CHINA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 186 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 187 CHINA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 188 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 189 CHINA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 190 CHINA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 221
TABLE 191 CHINA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 221
9.4.4 INDIA 221
9.4.4.1 Growing awareness regarding patient safety due to healthcare negligence to drive growth 221
TABLE 192 INDIA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 222
TABLE 193 INDIA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 194 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 195 INDIA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 223
TABLE 196 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 197 INDIA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 198 INDIA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 225
TABLE 199 INDIA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 225
9.4.5 REST OF ASIA PACIFIC 225
TABLE 200 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 226
TABLE 201 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 202 REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 203 REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 227
TABLE 204 REST OF ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 205 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 206 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 229
TABLE 207 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 229
9.5 LATIN AMERICA 229
TABLE 208 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 230
TABLE 209 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 230
TABLE 210 LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 211 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 212 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 232
TABLE 213 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 214 LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 215 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 233
TABLE 216 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 233

9.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS 234
9.5.2 BRAZIL 234
9.5.2.1 High incidence of chronic diseases to drive market 234
TABLE 217 BRAZIL: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 235
TABLE 218 BRAZIL: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 219 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 220 BRAZIL: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 236
TABLE 221 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 222 BRAZIL: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 223 BRAZIL: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 237
TABLE 224 BRAZIL: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 237
9.5.3 MEXICO 238
9.5.3.1 Disruptive technologies and public-private partnerships to boost growth 238
TABLE 225 MEXICO: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 238
TABLE 226 MEXICO: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 227 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 228 MEXICO: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 240
TABLE 229 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 230 MEXICO: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 231 MEXICO: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 241
TABLE 232 MEXICO: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 241
9.5.4 REST OF LATIN AMERICA 242
TABLE 233 REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 242
TABLE 234 REST OF LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 235 REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 236 REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 243
TABLE 237 REST OF LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 238 REST OF LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 239 REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 245
TABLE 240 REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 245
9.6 MIDDLE EAST & AFRICA 245
TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 246
TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 246
TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 244 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 245 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 248
TABLE 246 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 249
TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 249
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS 250
9.6.2 GCC 250
9.6.2.1 Focus on enhancing patient care to drive market 250
TABLE 250 GCC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 250
TABLE 251 GCC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 252 GCC: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 253 GCC: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 252
TABLE 254 GCC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 255 GCC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 256 GCC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 253
TABLE 257 GCC: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 253
9.6.3 REST OF MIDDLE EAST & AFRICA 254
TABLE 258 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 254
TABLE 259 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 260 REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 261 REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 255
TABLE 262 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 263 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 264 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 257
TABLE 265 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 257
10 COMPETITIVE LANDSCAPE 258
10.1 INTRODUCTION 258
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 258
TABLE 266 KEY DEVELOPMENTS BY MAJOR PLAYERS BETWEEN JANUARY 2020 AND DECEMBER 2023 259
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022 260
FIGURE 35 HEALTHCARE SIMULATION MARKET: REVENUE SHARE ANALYSIS OF MARKET PLAYERS 260
10.4 MARKET SHARE ANALYSIS 261
FIGURE 36 HEALTHCARE SIMULATION: MARKET SHARE ANALYSIS 261
10.5 MARKET RANKING ANALYSIS 262
FIGURE 37 HEALTHCARE SIMULATION MARKET RANKING, 2022 262
10.6 BRAND/PRODUCT COMPARATIVE ANALYSIS 263
FIGURE 38 HEALTHCARE SIMULATION: TOP TRENDING BRAND/PRODUCTS 263
10.6.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT & SERVICE 264
FIGURE 39 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT & SERVICE 264
10.6.1.1 Laerdal Medical 264
10.6.1.2 CAE Inc. 264
10.6.1.3 Simulab 264
10.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TECHNOLOGY PROVIDER COMPANY 265
FIGURE 40 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TECHNOLOGY PROVIDER COMPANY 265
10.6.2.1 Siemens Healthineers AG 265
10.6.2.2 Veradigm 265
10.6.2.3 Koninklijke Philips N.V. 266
10.7 COMPANY EVALUATION MATRIX 266
10.7.1 STARS 266
10.7.2 EMERGING LEADERS 266
10.7.3 PERVASIVE PLAYERS 267
10.7.4 PARTICIPANTS 267
FIGURE 41 HEALTHCARE SIMULATION MARKET: COMPANY EVALUATION MATRIX, 2022 267
10.7.5 COMPANY FOOTPRINT ANALYSIS 268
TABLE 267 OVERALL COMPANY FOOTPRINT (20 COMPANIES) 268
TABLE 268 COMPANY PRODUCT & SERVICE FOOTPRINT ANALYSIS (20 COMPANIES) 269
TABLE 269 COMPANY REGIONAL FOOTPRINT ANALYSIS (20 COMPANIES) 270
10.8 STARTUP/SME EVALUATION MATRIX 271
10.8.1 PROGRESSIVE COMPANIES 271
10.8.2 RESPONSIVE COMPANIES 271
10.8.3 DYNAMIC COMPANIES 271
10.8.4 STARTING BLOCKS 271
FIGURE 42 HEALTHCARE SIMULATION MARKET: STARTUP/SME EVALUATION MATRIX, 2022 272
10.8.5 COMPETITIVE BENCHMARKING 273
TABLE 270 HEALTHCARE SIMULATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 273
TABLE 271 HEALTHCARE SIMULATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 274
10.9 COMPETITIVE SCENARIO 275
10.9.1 PRODUCT LAUNCHES 275
TABLE 272 HEALTHCARE SIMULATION MARKET: PRODUCT LAUNCHES, JANUARY 2020– DECEMBER 2023 275
10.9.2 DEALS 275
TABLE 273 HEALTHCARE SIMULATION MARKET: DEALS, JANUARY 2020–DECEMBER 2023 275
10.9.3 OTHER DEVELOPMENTS 276
TABLE 274 HEALTHCARE SIMULATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020– DECEMBER 2023 276
11 COMPANY PROFILES 277
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
11.1 KEY PLAYERS 277
11.1.1 CAE INC. 277
TABLE 275 CAE INC.: BUSINESS OVERVIEW 277
FIGURE 43 CAE INC.: COMPANY SNAPSHOT (2022) 278
11.1.2 LAERDAL MEDICAL 282
TABLE 276 LAERDAL MEDICAL: BUSINESS OVERVIEW 282
11.1.3 GAUMARD SCIENTIFIC CO. 288
TABLE 277 GAUMARD SCIENTIFIC CO.: BUSINESS OVERVIEW 288
11.1.4 KYOTO KAGAKU 299
TABLE 278 KYOTO KAGAKU: BUSINESS OVERVIEW 299
11.1.5 LIMBS & THINGS 306
TABLE 279 LIMBS & THINGS: BUSINESS OVERVIEW 306
11.1.6 MENTICE AB 311
TABLE 280 MENTICE AB: BUSINESS OVERVIEW 311
FIGURE 44 MENTICE AB: COMPANY SNAPSHOT (2022) 312
11.1.7 SIMULAB CORPORATION 316
TABLE 281 SIMULAB CORPORATION: BUSINESS OVERVIEW 316
11.1.8 SIMULAIDS 324
TABLE 282 SIMULAIDS: BUSINESS OVERVIEW 324
11.1.9 INTELLIGENT ULTRASOUND GROUP PLC 332
TABLE 283 INTELLIGENT ULTRASOUND GROUP PLC.: BUSINESS OVERVIEW 332
FIGURE 45 INTELLIGENT ULTRASOUND GROUP PLC: COMPANY SNAPSHOT (2022) 333
11.1.10 OPERATIVE EXPERIENCE INC. 336
TABLE 284 OPERATIVE EXPERIENCE INC.: BUSINESS OVERVIEW 336
11.1.11 SURGICAL SCIENCE SWEDEN AB 338
TABLE 285 SURGICAL SCIENCE SWEDEN AB: BUSINESS OVERVIEW 338
FIGURE 46 SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2022) 338
11.1.12 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC) 341
TABLE 286 CARDIONICS INC.: BUSINESS OVERVIEW 341
11.1.13 VIRTAMED AG 342
TABLE 287 VIRTAMED AG: BUSINESS OVERVIEW 342
11.1.14 SYNBONE AG 344
TABLE 288 SYNBONE AG: BUSINESS OVERVIEW 344
11.1.15 INGMAR MEDICAL 346
TABLE 289 INGMAR MEDICAL: BUSINESS OVERVIEW 346
11.1.16 MEDICAL-X 348
TABLE 290 MEDICAL-X: BUSINESS OVERVIEW 348
11.1.17 KAVO DENTAL GMBH 351
TABLE 291 KAVO DENTAL GMBH: BUSINESS OVERVIEW 351
11.1.18 ALTAY SCIENTIFIC 352
TABLE 292 ALTAY SCIENTIFIC: BUSINESS OVERVIEW 352
11.1.19 TRUCORP LTD. 357
TABLE 293 TRUCORP LTD.: BUSINESS OVERVIEW 357
11.1.20 SIMENDO B.V. 359
TABLE 294 SIMENDO B.V.: BUSINESS OVERVIEW 359
11.2 OTHER PLAYERS 360
11.2.1 HAAG-STREIT SIMULATION GMBH 360
11.2.2 SYMGERY 360
11.2.3 HRV SIMULATION 361
11.2.4 SYNAPTIVE MEDICAL 361
11.2.5 INOVUS MEDICAL 362
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 363
12.1 DISCUSSION GUIDE 363
12.2 CUSTOMIZATION OPTIONS 369
12.3 RELATED REPORTS 369
12.4 AUTHOR DETAILS 370

★調査レポート[世界の医療シミュレーション市場（～2028年）：提供別（シミュレーション（患者-忠実度、外科-腹腔鏡、CVD、整形、脊椎、婦人科、超音波）、トレーニングサービス）、技術別（3Dプリント、バーチャル患者、手術リハーサル）、エンドユーザー別、地域別] (コード：HIT2828-24)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医療シミュレーション市場（～2028年）：提供別（シミュレーション（患者-忠実度、外科-腹腔鏡、CVD、整形、脊椎、婦人科、超音波）、トレーニングサービス）、技術別（3Dプリント、バーチャル患者、手術リハーサル）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の非破壊試験＆検査市場（～2030年）：方法別（表面検査、容積検査、目視検査、その他）、サービス別（トレーニングサービス、校正サービス、検査サービス、機器レンタルサービス）、技術別、エンドユーザー別、地域別
  • 世界の3D技術市場（～2030年）：製品別（3Dプリント、3Dメガネ、その他）、用途別（メディア＆エンターテインメント、自動車、工業、医療、その他）、地域別
  • 世界の無人航空機訓練市場（2024年～2034年）：ドローン種類別（固定翼ドローン、ハイブリッドドローン、回転翼ドローン）、訓練種類別（シミュレーション（フルフライトシミュレータ、固定ベースシミュレータ）、訓練、認証（飛行訓練装置、地上訓練、技術ノウハウ、その他））、操作別（自律型ドローン、遠隔操縦ドローン）、エンドユーザー別（初心者、プロフェッショナル）、地域別
  • 世界の量子コンピューティング市場（～2029年）：提供別、展開別（オンプレミス、クラウド）、用途別（最適化、シミュレーション、機械学習）、技術別（トラップイオン、量子アニーリング、超伝導量子ビット）、エンドユーザー別、地域別
  • 世界の医療シミュレーション市場：主要プレイヤーの市場シェアとランキング2024年

    • ◆H&Iグローバルリサーチのお客様（例）◆